About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

B-276362 1 (1997-06-06)

handle is hein.gao/gaocrptafyb0001 and id is 1 raw text is: 


oComptroller General
             of the United States
             Washington, D.C. 20548
             Decision




             Matter of: Pfizer, Incorporated

             File:        B-276362

             Date:        June 6, 1997

             Kenneth B. Weckstein, Esq., and Shlomo Katz, Esq., Epstein, Becker & Green, P.C.,
             for the protester.
             Philip S. Kaufman, Esq., and Barbara J. Stuetzer, Esq., Department of Veterans
             Affairs, for the agency.
             Paul E. Jordan, Esq., and Paul Lieberman, Esq., Office of the General Counsel, GAO,
             participated in the preparation of the decision.
             DIGEST

             In solicitation for blanket purchase agreement under Federal Supply Schedule
             contracts, agency decision to use only price and price-related evaluation factors is
             unobjectionable where, prior to issuance of solicitation, agency reasonably
             determines that competing drugs are essentially technically equal.
             DECISION

             Pfizer, Incorporated protests the evaluation criteria in a request for quotation (RFQ)
             for a blanket purchase agreement (BPA) issued by the Department of Veterans
             Affairs (VA) for a drug class referred to as long-acting alpha blockers. The
             solicitation was issued with evaluation criteria consisting only of price factors.1
             Pfizer argues that the agency should have included technical criteria to take into
             consideration certain allegedly meaningful differences in the competing drugs.

             We deny the protest.

             BACKGROUND

             This RFQ was issued as part of a broader program underway at VA to standardize
             pharmaceuticals and medic al/surgical items in order to achieve concentrated buying
             power. Since the Veterans Health Administration (VHA) expends approximately
             $1 billion on pharmaceuticals each year, the VA seeks to accomplish its greater


             'The solicitation was originally issued as a request for proposals and contained a
             section entitled technical evaluation, which listed only price and price-related
             evaluation factors. In response to Pfizer's protest, the VA amended the solicitation
             to make it an RFP, to entitle it a blanket purchase agreement quote, and to delete
             the reference to a technical evaluation.

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Contact us for annual subscription options:

Already a HeinOnline Subscriber?

profiles profiles most